The Product Launch Tracker

11.04.2024 | Article

Product Launch Tracker: eHCPs celebrated the first approved treatment for patients with NASH

Discover which drug approvals HCPs are talking about online

By Alexandra Maria Chatziioannidou

12.03.2024 | Article

Product Launch Tracker: eHCPs are enthusiastic about the first cellular therapy for advanced melanoma.

Discover which new drug approvals HCPs are talking about online

By Alexandra Maria Chatziioannidou

01.02.2024 | Article

Product Launch Tracker: eHCPs celebrate approval in cervical cancer

Discover which new drug approvals HCPs are talking about online

By Alexandra Maria Chatziioannidou

05.01.2024 | Article

Product Launch Tracker: Hundreds of eHCPs are enthusiastic about the first Sickle Cell Disease gene therapies.

Discover which new drug approvals HCPs are talking about

By Alexandra Maria Chatziioannidou

13.12.2023 | Article

Product Launch Tracker: eHCPs optimistic about Wegovy competitor’s obesity approval

Discover which new drug approvals HCPs are talking about

By Alexandra Maria Chatziioannidou

02.11.2023 | Article

Product Launch Tracker: eHCPs had positive reaction to the approval of the Novavax COVID-19 vaccine.

Discover what new drug approvals HCPs are talking about

By Alexandra Maria Chatziioannidou

06.10.2023 | Article

Product Launch Tracker: eHCPs had mixed opinions on the updated mRNA COVID-19 booster vaccines.

Discover what healthcare professionals (HCPs) think about pharmaceutical companies

By Alexandra Maria Chatziioannidou

01.09.2023 | Article

Product Launch Tracker: eHCPs thrilled about approval of first oral treatment for postpartum depression

Discover which new drug approvals HCPs are talking about

By Alexandra Maria Chatziioannidou

02.08.2023 | Article

Product Launch Tracker: eHCPs applauded the approval of Opill, the first non-prescription contraceptive.

Discover which new drug approvals HCPs are talking about

By Alexandra Maria Chatziioannidou

08.07.2023 | Article

Product Launch Tracker: eHCPs are delighted with the approval of Talzenna for prostate cancer.

Discover which new drug approvals HCPs are talking about

By Alexandra Maria Chatziioannidou

01.05.2023 | Article

Product Launch Tracker: HCPs are captivated by the approval of Vowst, a faecal microbiota product.

Discover which new drug approvals HCPs are talking about

By Alexandra Maria Chatziioannidou

01.04.2023 | Article

Product Launch Tracker: HCPs are enthusiastic about the approval of two nasal sprays and an antifungal treatment.

Discover which new drug approvals HCPs are talking about

By Alexandra Maria Chatziioannidou

05.02.2023 | Article

Product Launch Tracker: HCPs start the year discussing approvals for Alzheimer’s and several cancer treatments.

HCP's in the month of Jan discussed online their thoughts on a new treatment for Alzheimer’s

By Paul Cranston

15.01.2023 | Article

Product Launch Tracker: HCPs discuss pre-Christmas approvals in precision medicine, oncology and infectious disease

At the start of the month, HCPs were interested in the first faecal microbiota product

By Paul Cranston

16.12.2022 | Article

Product Launch Tracker: HCPs discuss first drug to delay type 1 diabetes and the approval of world’s most expensive treatment

In Nov. 2022 HCPs discussed treatments for multiple myeloma, gene therapy and diabetes.

By Paul Cranston

14.11.2022 | Article

Product Launch Tracker: HCPs share optimism for approvals in heart failure, obesity and multiple myeloma

HCP's shared the news on product approvals for issues like obesity, multiple myeloma, etc.

By Paul Cranston and Tomi Shobande

05.07.2022 | Article

Product Launch Tracker: HCPs discuss approvals including for the prevention of smallpox and monkeypox.

HCPs also held around the approval of treatments for monkeypox

By Paul Cranston and Tomi Shobande

02.07.2022 | Article

Product Launch Tracker: HCPs celebrate 5th agnostic approval in Cancer alongside other approvals

with notable excitement being found for the FDA’s approval of Novartis’ 5th agnostic...

By Paul Cranston and Tomi Shobande

06.06.2022 | Article

Product Launch Tracker: HCPs excited by approvals for Eli Lilly, Novartis, Sanofi and Regeneron

Over the last month, HCPs discussed product approvals for the treatment of a variety...

By Paul Cranston and Tomi Shobande

19.05.2022 | Article

Product Launch Tracker: HCPs excited for BMS’ newly approved ‘Camzyos’

Discover which new drug approvals HCPs are talking about

By Paul Cranston and Tomi Shobande

12.04.2022 | Article

Product Launch Tracker: HCPs discuss approvals for several cancer treatments and a fourth dose of COVID-19 vaccines

HCPs discuss approvals for several cancer treatments and a fourth dose of COVID-19 vaccines

By Paul Cranston and Tomi Shobande

11.03.2022 | Article

Product Launch Tracker: Approvals for Boehringer Ingelheim, Eli Lilly, and Novo Nordisk focus of HCP conversations

HCPs discuss approvals for Boehringer Ingelheim, Eli Lilly, and Novo Nordisk

By Paul Cranston and Tomi Shobande

09.02.2022 | Article

Product Launch Tracker: HCPs celebrate new treatments for metastatic melanoma and non-small cell lung cancer

HCPs also shared the news of approvals of treatments for NSCLC

By Paul Cranston and Tomi Shobande

10.01.2022 | Article

Product Launch Tracker: Pre-Christmas approvals drive HCPs conversations

Discover which new drug approvals dominated HCPs conversations pre-Christmas...

By Paul Cranston and Tomi Shobande

01.12.2021 | Article

Product Launch Tracker: HCPs welcome approvals for MSD’s Keytruda and Takeda’s Livtencity

Discover which new drug approvals HCPs are talking about

By Paul Cranston and Tomi Shobande

01.10.2021 | Article

Product Launch Tracker: FDA’s Pfizer vaccine approval continues to drive HCPs conversations

Discover which new drug approvals and launches HCPs are talking about

By Francesca Gan and Chawanzi Chintu

01.08.2021 | Article

Product Launch Tracker: HCPs celebrate Merck & Co and Bayer approvals, while discussing Moderna’s extension at length

Discover which new drug approvals HCPs are talking about

By Aaron Pitkin